ArticleCEN case reports2026
Full-house nephropathy associated with mantle cell lymphoma.
Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An 82-year-old man was admitted to our hospital with edema on the upper and lower extremities that had worsened over the past 5 months. He was diagnosed with nephrotic syndrome and acute renal failure. A computed tomography evaluation revealed generalized lymphadenopathy and splenomegaly. A bone marrow biopsy confirmed the diagnosis of mantle cell lymphoma (MCL). A renal biopsy showed full-house nephropathy with diffuse global endocapillary proliferation and electron-dense deposits in the epithelial, endothelial, and mesangial areas. Lymphoma cells infiltrated the renal interstitium but were not observed within the glomeruli. The blood test demonstrated low complement levels, positive anti-single-stranded deoxyribonucleic acid antibody and anti-double-stranded deoxyribonucleic acid antibody, but negative for antinuclear antibody; no other physical findings consistent with systemic lupus erythematosus were observed. After the initiation of the treatment for MCL, the renal function and urinary protein level improved. The patient was diagnosed with immune complex-associated glomerulonephritis, resembling lupus nephritis, secondary to MCL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.